vimarsana.com

Ls Sclc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Evolving Treatment Landscape of Small Cell Lung Cancer

Closing out their program on small cell lung cancer management, Laurent Greiller, MD, and Christian Grohé, MD, highlight what excites them most about the evolving treatment paradigm.

Christian grohLaurent greillerEvolving paradigmsEvolving treatment landscapeSmall cell lungSmall cell lung cancerLimited stage sclcExtensive stage sclcLs sclcEs sclcNovel therapyCombination therapyClinical trialsBispecific therapyBispecific antibodiesAdverse events

Clinical Data With Lurbinectedin in Small Cell Lung Cancer

Key opinion leaders share a focused discussion on lurbinectedin and its evolving role in small cell lung cancer following frontline therapy.

Evolving paradigmsData with lurbinectedinSmall cell lungSmall cell lung cancerLimited stage sclcExtensive stage sclcLs sclcEs sclcSecond line therapySecond line treatmentImforte trialImforte studyPlatinum resistantPlatinum sensitiveMaintenance therapyAdverse events

Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?

A brief review of the role that immunotherapy agents play in the frontline management of patients with small cell lung cancer.

Evolving paradigmsCell lung cancerSmall cell lung cancerLimited stage sclcExtensive stage sclcLs sclcEs sclcFirst line treatmentFrontline treatmentFirst line therapyFrontline therapyChemo ioTrio therapyCombination therapyNivo ipiIpi nivo

Current Strategies in Diagnosis and Classification of Small Cell Lung Cancer

Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, make introductions and review the current paradigm for small cell lung cancer diagnosis and classification.

Laurent greillerChristian grohEvolving paradigmsSmall cell lungSmall cell lung cancerLimited stage sclcExtensive stage sclcLs sclcEs sclcTnm stagingPatient agePerformance statusPatient workupDiagnostic testingSclc diagnosisSclc staging

vimarsana © 2020. All Rights Reserved.